756821-39-3

Upstream product

• 756821-35-9 (1R,6R)-acetic acid 6-(N-allyl-N-p-toluenesulfonylamino)cyclohept-3-enyl ester 
• 18303-04-3 N-[(tert-butoxy)carbonyl]-4-methylbenzenesulfonamide 
• 756821-38-2 (1R,6R)-acetic acid 6-(N-p-toluenesulfonylamino)cyclohept-3-enyl ester 
• 756821-37-1 (1R,6R)-N-(tert-butoxycarbonyl)-N-[(6-tert-butyldimethylsilanyloxy)cyclohept-3-enyl]toluensulfonamide 

Downstream Products

• 26648-71-5 (-)-halosaline 
• 756821-42-8 (2'R,4S)-5-[1'-(toluene-4-sulfonyl)-1',2',3',6'-tetrahydropyridin-2'-yl]pentane-1,2,4-triol 
• 756821-40-6 (2R,2'R)-1-[1'-(toluene-4-sulfonyl)-1',2',3',6'-tetrahydropyridin-2'-yl]pent-4-en-2-ol 

Relevant academic research and scientific papers

Concise asymmetric synthesis of (-)-halosaline and (2R,9aR)-(+)-2-hydroxy- quinolizidine by ruthenium-catalyzed ring-rearrangement metathesis

A ruthenium-catalyzed ring opening-ring closing metathesis reaction serves as the key step in the stereoselective synthesis of a new enantiopure 2-substituted-4,5-dehydropiperidine skeleton, a valuable intermediate for the synthesis of piperidine alkaloid